Anti-E1E2 antibodies status prior therapy favors direct-acting antiviral treatment efficacy.
about
Anti-E1E2 antibodies status prior therapy favors direct-acting antiviral treatment efficacy.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh
2018年學術文章
@zh-hant
name
Anti-E1E2 antibodies status pr ...... antiviral treatment efficacy.
@en
Anti-E1E2 antibodies status pr ...... antiviral treatment efficacy.
@nl
type
label
Anti-E1E2 antibodies status pr ...... antiviral treatment efficacy.
@en
Anti-E1E2 antibodies status pr ...... antiviral treatment efficacy.
@nl
prefLabel
Anti-E1E2 antibodies status pr ...... antiviral treatment efficacy.
@en
Anti-E1E2 antibodies status pr ...... antiviral treatment efficacy.
@nl
P2093
P50
P1476
Anti-E1E2 antibodies status pr ...... antiviral treatment efficacy.
@en
P2093
Caroline Scholtès
Christian Trépo
Isabelle Bordes
Marianne Maynard
Marie-Anne Petit
Pascale Berthillon
Pierre Pradat
Stéphanie Crouy
Sylvie Larrat
Vincent Leroy
P304
P356
10.1016/J.CLINRE.2018.02.002
P577
2018-03-15T00:00:00Z